EV/EBITDA:
-20.99+0.23(+1.08%)Summary
- As of today, TVTX EV/EBITDA is -20.99, with a rise of +0.23 (+1.08%) during the most recent trading session on October 22, 2025.
- Over the past year, TVTX EV/EBITDA has dropped by -14.54 (-225.43%).
- TVTX EV/EBITDA is now -3582.46% below its all-time high of -0.57.
Performance
TVTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TVTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.1% | -1.1% | -1.1% |
| 1M1 Month | -7.8% | +7.8% | +8.1% |
| 3M3 Months | -71.5% | +71.5% | +75.5% |
| 6M6 Months | -152.0% | +70.0% | +73.0% |
| YTDYTD | -187.1% | +62.8% | +57.8% |
| 1Y1 Year | -225.4% | +65.9% | +52.9% |
| 5Y5 Years | -11.8% | +193.9% | +30.4% |
TVTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -18.34 | -14.4% | -21.29 | +1.4% |
| 3M | 3-Month | -11.99 | -75.1% | -21.29 | +1.4% |
| 6M | 6-Month | -7.44 | -182.1% | -21.29 | +1.4% |
| 1Y | 1-Year | -6.24 | -236.4% | -21.29 | +1.4% |
| 3Y | 3-Year | -0.57 | -3582.5% | -21.29 | +1.4% |
| 5Y | 5-Year | -0.57 | -3582.5% | -34.23 | +38.7% |
| All-Time | All-Time | -0.57 | -3582.5% | -392.61 | +94.7% |
TVTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -20.99(-187.1%) |
| 2024 | -7.31(-335.1%) |
| 2023 | -1.68(+67.1%) |
| 2022 | -5.11(+65.3%) |
| 2021 | -14.74(+42.7%) |
| Date | Value |
|---|---|
| 2020 | -25.72(+38.0%) |
| 2017 | -41.47(-10.0%) |
| 2015 | -37.70(-625.0%) |
| 2014 | -5.20(+8.8%) |
| 2013 | -5.70 |
FAQ
- What is Travere Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Travere Therapeutics, Inc.?
- What is TVTX EV/EBITDA year-to-date change?
- What is Travere Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Travere Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TVTX is -20.99
What is the all-time high EV/EBITDA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high EV/EBITDA is -0.57
What is TVTX EV/EBITDA year-to-date change?
Travere Therapeutics, Inc. EV/EBITDA has changed by -13.68 (-187.14%) since the beginning of the year
What is Travere Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TVTX EV/EBITDA has changed by -14.54 (-225.43%)